Armata Pharmaceuticals (ARMP) Assets Average: 2014-2018
Historic Assets Average for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $11.2 million.
- Armata Pharmaceuticals' Assets Average fell 22.67% to $11.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was $11.2 million, marking a year-over-year decrease of 22.67%. This contributed to the annual value of $14.6 million for FY2017, which is 41.00% down from last year.
- Armata Pharmaceuticals' Assets Average amounted to $11.2 million in Q3 2018, which was down 14.47% from $13.1 million recorded in Q2 2018.
- Armata Pharmaceuticals' Assets Average's 5-year high stood at $39.4 million during Q1 2014, with a 5-year trough of $11.2 million in Q3 2018.
- Its 3-year average for Assets Average is $18.5 million, with a median of $14.7 million in 2017.
- Per our database at Business Quant, Armata Pharmaceuticals' Assets Average increased by 8.30% in 2015 and then slumped by 48.89% in 2017.
- Quarterly analysis of 5 years shows Armata Pharmaceuticals' Assets Average stood at $30.3 million in 2014, then rose by 8.30% to $32.8 million in 2015, then plummeted by 32.61% to $22.1 million in 2016, then tumbled by 43.61% to $12.5 million in 2017, then fell by 22.67% to $11.2 million in 2018.
- Its last three reported values are $11.2 million in Q3 2018, $13.1 million for Q2 2018, and $12.8 million during Q1 2018.